Candel Therapeutics Inc CADL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:00 AM EDT
13.00quote price arrow up+0.30 (+2.40%)
Volume
9,989
Close
12.70quote price arrow down-1.30 (-9.29%)
Volume
9,989
52 week range
0.66 - 14.30
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close12.70
  • 52 Week High14.30
  • 52 Week High Date05/16/24
  • 52 Week Low0.66
  • 52 Week Low Date11/03/23

Key Stats

  • Market Cap377.758M
  • Shares Out29.74M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.92
  • YTD % Change763.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close12.70
  • 52 Week High14.30
  • 52 Week High Date05/16/24
  • 52 Week Low0.66
  • 52 Week Low Date11/03/23
  • Market Cap377.758M
  • Shares Out29.74M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.92
  • YTD % Change763.95

RATIOS/PROFITABILITY

  • EPS (TTM)-1.29
  • P/E (TTM)-9.86
  • Fwd P/E (NTM)-79.38
  • EBITDA (TTM)-35.279M
  • ROE (TTM)-163.77%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-102,990.30%
  • Debt To Equity (MRQ)329.85%

EVENTS

  • Earnings Date08/07/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Candel Therapeutics Inc

 

Profile

MORE
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The Company has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the...
Paul Manning
Independent Chairman of the Board
Paul Tak M.D., Ph.D.
President, Chief Executive Officer, Director
Charles Schoch
Interim Chief Financial Officer
Christopher Matheny Pharm.D.
Vice President - Development Leader
Address
117 Kendrick Street,, Suite 450
Needham, MA
02494
United States

Top Peers

SYMBOLLASTCHG%CHG
ACRV
Acrivon Therapeutics Inc
8.56-0.09-1.04%
IVVD
Invivyd Inc
2.45-0.01-0.41%
INZY
Inozyme Pharma Inc
4.73+0.06+1.28%
ATNM
Actinium Pharmaceuticals Inc
9.85+0.12+1.23%
VTYX
Ventyx Biosciences Inc
4.98+0.79+18.85%